{
  "pmcid": "11297483",
  "sha256": "5b59354cba412a896d79015048a02ce5a26587679b1b9f34714dbe2749c97776",
  "timestamp_utc": "2025-11-09T23:14:34.168614+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.818728918140685,
    "reading_ease": 18.784292472233687,
    "word_count": 286
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Evaluation of PERCIST in Predicting Pathologic Response in NSCLC: A Retrospective Study"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "This retrospective study analyzed 130 patients from the Setouchi Lung Cancer Group"
      },
      "Participants": {
        "score": 2,
        "evidence": "130 patients from the Setouchi Lung Cancer Group who underwent FDG-PET imaging before and after induction therapy prior to planned surgical resection for NSCLC between 2007 and 2016."
      },
      "Intervention": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the predictive value of Positron Emission Tomography Response Criteria in Solid Tumors (PERCIST) for pathologic response."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was pathologic complete response (pCR), measured postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 2,
        "evidence": "blinded radiologists and pathologists assessing imaging and clinical data."
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Pathologic studies revealed pCR in 42 (32.3%) patients."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "PERCIST was significantly correlated with pathologic response (p < 0.001). The sensitivity, specificity, and accuracy of PERCIST for predicting pCR were 16.7%, 88.6%, and 65.4%, respectively."
      },
      "Harms": {
        "score": 1,
        "evidence": "no adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding sources were not specified."
      }
    },
    "total_score": 11,
    "max_score": 25
  }
}